Jihyeon Ha

Title: Jihyeon Ha: Innovator in Antibody-Drug Conjugates

Introduction

Jihyeon Ha is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates.

Latest Patents

Jihyeon Ha holds a patent for "Antibody-drug conjugates comprising anti-B7-H3 antibodies." This patent relates to antibody-drug conjugates (ADCs) wherein one or more active agents are conjugated to an anti-B7-H3 antibody through a linker. The linker may comprise a unit that covalently links active agents to the antibody. The disclosure further relates to monoclonal antibodies and antigen-binding fragments, variants, multimeric versions, or bispecifics thereof that specifically bind B7-H3. Additionally, it includes methods of making and using these anti-B7-H3 antibodies and antigen-binding fragments in various therapeutic, diagnostic, and prophylactic indications.

Career Highlights

Throughout his career, Jihyeon Ha has worked with several prominent companies, including Intocell, Inc. and Y-Biologics Inc. His work has focused on advancing the applications of antibody-drug conjugates in medical treatments.

Collaborations

Jihyeon Ha has collaborated with notable colleagues such as Taekyo Park and Sunyoung Kim. Their combined expertise has contributed to the innovative developments in the field of biotechnology.

Conclusion

Jihyeon Ha's work in antibody-drug conjugates represents a significant advancement in therapeutic options for various diseases. His contributions continue to influence the field of biotechnology and improve patient outcomes.